DOCSLIB.ORG

Dr. Duke's Phytochemical and Ethnobotanical Databases List of Chemicals for BPH

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Dr. Duke's Phytochemical and Ethnobotanical Databases List of Chemicals for BPH Dr. Duke's Phytochemical and Ethnobotanical Databases List of Chemicals for BPH Chemical Activity Count (+)-8-16-BETA-HYDROXYBERSALDEGENIN-1,3,5-ORTHOACETATE 1 (+)-ALPHA-VINIFERIN 1 (+)-CATECHIN 9 (+)-DIMETHYLISOLARICIRESINOL-2-ALPHA-XYLOSIDE 1 (+)-EUDESMA-4(14),7(11)-DIENE-3-ONE 1 (+)-GALLOCATECHIN 2 (+)-HERNANDEZINE 1 (+)-ISOCORYDINE 1 (+)-MATRINE 1 (+)-PSEUDOEPHEDRINE 1 (+)-SYRINGARESINOL 1 (+)-SYRINGARESINOL-DI-O-BETA-D-GLUCOSIDE 1 (+)-TETRANDRINE 1 (-)-16,17-DIHYDROXY-16BETA-KAURAN-19-OIC 1 (-)-ALPHA-BISABOLOL 2 (-)-BETONICINE 1 (-)-BISPARTHENOLIDINE 2 (-)-BORNYL-CAFFEATE 2 (-)-BORNYL-FERULATE 2 (-)-BORNYL-P-COUMARATE 2 (-)-DICENTRINE 1 (-)-EPIAFZELECHIN 1 (-)-EPICATECHIN 8 (-)-EPICATECHIN-3-O-GALLATE 1 (-)-EPICATECHIN-GALLATE 1 (-)-EPIGALLOCATECHIN 4 (-)-EPIGALLOCATECHIN-3-GALLATE 1 Chemical Activity Count (-)-EPIGALLOCATECHIN-3-O-GALLATE 1 (-)-EPIGALLOCATECHIN-GALLATE 11 (-)-HYDROXYJASMONIC-ACID 1 (-)-MAACKIAIN-3-O-GLUCOSIDE 1 (-)-MELLEIN 1 (1'S)-1'-ACETOXYCHAVICOL-ACETATE 5 (15:1)-CARDANOL 3 (1S-2-TRANS-4R-6R-7-TRANS)-CEMBRA-2,7,12-(20-TRIENE-4,6,11-TRIOL) 1 (1S-2-TRANS-4R-6R-7-TRANS-11-TRANS)-CEMBRA-2,7,11-TRIENE-4,6-DIOL 1 (1S-2-TRANS-4S-6R-7-TRANS)-CEMBRA-2,7,12-(20-TRIENE-4,6,11-TRIOL) 1 (1S-2-TRANS-4S-6R-7-TRANS-11-TRANS)-CEMBRA-2,7,11-TRIENE-4,6-DIOL 1 (2R)-(12Z,15Z)-2-HYDROXY-4-OXOHENEICOSA-12,15-DIEN-1-YL-ACETATE 1 (2S)-5-METHOXY-6-METHYLFLAVAN-7-OL 1 (7R,10R)-CAROTA-1,4-DIENALDEHYDE 1 (E)-4-(3',4'-DIMETHOXYPHENYL)-BUT-3-EN-OL 3 (Z)-1,8-PENTADECADIENE 1 1'-ACETOXY-EUGENOL-ACETATE 1 1'-ACETOXYCHAVICOL-ACETATE 1 1,10-EPOXYNOBILIN 1 1,2,11,13,2,3'-HEXAHYDROVERNODALIN 1 1,2,4-TRIHYDROXY-BENZENE 1 1,2,6-TRI-O-GALLOYL-BETA-D-GLUCOSE 1 1,3,5-TRIHYDROXY-BENZENE 1 1,4-NAPHTHOQUINONE 2 1,5-DIHYDROXY-8-METHOXYXANTHONE 1 1,7-BIS(3,4-DIHYDROXYPHENYL)HEPTA-4E,6E-DIEN-3-ONE 1 1,7-BIS-(4-HYDROXYPHENYL)-1,4,6-HEPTATRIEN-3-ONE 1 2 Chemical Activity Count 1,8-CINEOLE 2 1,8-DIHYDROXY-9-ANTHRONE 1 1-ACETOXYCHAVICOL 1 1-ACETOXYEUGENOL 1 1-METHOXYCANTHIN-6-ONE 1 1-MONOLAURIN 2 1-MONOMYRISTIN 2 1-O-(2,3,4-TRIHYDROXY-3-METHYL)-BUTYL-6-O-FERULOYL-BETA-D-GLUCOPYRANOSIDE 1 1-PENTADECENE 1 10-ACETOXY-8-HYDROXY-9-ISOBUTYLOXY-6-METHOXYTHYMOL 2 10-DEHYDROGINGERDIONE 2 10-EPIEUPATOROXIN 1 10-GINGERDIONE 2 10-HYDROXYCAMPTOTHECIN 3 10-METHOXYCAMPTOTHECIN 1 12-HYDROXYDAPHNETOXIN 1 13',II8-BIAPIGENIN 3 13-OXYINGENOL-ESTER 1 15-NONACOSANONE 1 16,17-DIHYDROXY-16BETA-KAURAN-19-OIC 1 16-ANHYDROGITOXIGEN 1 16-BETA-HYDROXYBERSALDEGENIN-1-ACETATE 1 16-BETA-HYDROXYBERSALDEGENIN-3-ACETATE 1 16-EPIMETHUENINE 2 16-HYDROXY-4,4,10,13-TETRAMETHYL-17-(4-METHYL-PENTYL)-HEXADECAHYDRO- 1 CYCLOPENTA[A]PHENANTHREN-3-ONE 16-HYDROXYINGENOL-ESTER 1 2',6'-DIMETHOXY-4'-HYDROXYACETOPHENONE 3 3 Chemical Activity Count 2'-ACETYLNERIIFOLIN 1 2'-O-GLYCOSYLVITEXIN 1 2,3,7-TRIHYDROXY-5-(3,4-DIHYDROXY-E-STYRYL)-6,7,8,9-TETRAHYDRO-5H- 1 BENZOCYCLOHEPTENE 2,3-DIHYDROXYBENZOIC-ACID 1 2,3-DIHYDROXYETHOXYACETOPHENONE 1 2,6-DIMETHOXYPHENOL 1 2-(3',4-DIPHENYL)-ETHANOL 1 2-(3-HYDROXY-4-METHOXY-STYRYL)-BENZOIC-ACID 1 2-AMINO-1,4-NAPTHOQUINONE 2 2-AMINO-4-METHYLHEX-5-YNOIC-ACID-(2S,4R)-2-AMINO-4-HYDROXYHEPT-6-YNOIC-ACID 1 2-BETA,3BETA-27-TRIHYDROXYOLEAN-12-ENE-23,28-DICARBOXYLIC-ACID 1 2-CAFFEOYL-OXY-3-{2-(4-HYDROXYBENZYL)-4,5-DIHYDROXY}PHENYLPROPIONIC-ACID 1 2-EPICUCURBITACIN-B 1 2-HYDROXY-3,4-DIMETHOXYBENZOIC-ACID-METHYL-ESTER 1 2-HYDROXY-4,4,7-TRIMETHYL-(4H)-NAPHTHALEN-1-ONE 1 2-PHENYLETHYL-ISOTHIOCYANATE 1 2-VINYL-4H-1,3-DITHIIN 1 20-DEOXYINGENOL-ESTER 1 22BETA-ESCIN 1 24-METHYLENE-CYCLOARTANOL 3 25,26-DIHYDROPHYSALIN-C 1 25,26-DIHYDROPHYSALIN-D 1 3',4',5,6,7,8-HEXAMETHOXYFLAVONE 1 3',4',5,7-TETRAHYDROXYFLAVONE 1 3',5,7-TRIHYDROXY-3,4'-DIMETHOXYFLAVONE 1 3'-DEMETHYLPODOPHYLLOTOXIN 1 3'-O-METHYL-CATECHIN 1 4 Chemical Activity Count 3,3',7-TRIMETHYL-ETHER-6-C-METHYLQUERCETIN 1 3,3'-DIINDOLYMETHANE 3 3,3'-DIMETHYLELLAGIC-ACID 1 3,3'-INDOYL-DIMETHANE 1 3,4,5-TRI-O-CAFFEOYLQUINIC-ACID 1 3,4-DICAFFEOYL-QUINIC-ACID 2 3,4-DIHYDROXYBENZOATE 1 3,4-HYDROXYCINNAMIC-ACID 1 3,4-METHYLENE-DIOXYCINNAMIC-ACID-BORNYL-ESTER 2 3,4-SECOTRITERPENE-ACID-20-EPI-KOETJAPIC-ACID 1 3,5,8,3',4'-PENTAHYDROXYFLAVONE 1 3,5-DI-O-CAFFEOYLQUINIC-ACID 2 3,5-DICAFFEOYL-QUINIC-ACID 1 3,5-DIHYDROXY-4-METHOXYBENZOIC-ACID-METHYL-ESTER 1 3,7,8,2',5'-PENTAHYDROXYFLAVONE 1 3,7-DIMETHYL-ETHER-6,8-DI-C-METHYLKAEMPFEROL 1 3,7-DIMETHYL-ETHER-6,8-DI-C-METHYLQUERCETIN 1 3,7-DIMETHYL-ETHER-6-C-METHYLQUERCETIN 1 3-(3,3-DIMETHYLALLYL)-5-(3-ACETYL-2,4-DIHYDROXY-5-METHYL-6-METHOXYBENZYL)- 1 PHLORACETOPHENONE 3-ACETYLACONITINE 1 3-BETA-23,28-TRIHYDROXY-12-OLEANENE-23-CAFFEATE 2 3-BETA-23,28-TRIHYDROXY-12-OLEANENE-3-BETA-CAFFEATE 2 3-BETA-HYDROXY-2,3-DIHYDROWITHANOLIDE-F 1 3-BETA-TRANS-(3,4-DIHYDROXYCINNAMOYLOXY)-20(29)-LUPEN-28-OIC-ACID 1 3-BETA-TRANS-(3,4-DIHYDROXYCINNAMOYLOXY)-OLEAN-12-EN-28-OIC-ACID 1 3-BETA-TRANS-(3,4-DIHYDROXYCINNAMOYLOXY)-OLEAN-18-EN-28-OIC-ACID 1 3-BUTENYL-ISOTHIOCYANATE 1 5 Chemical Activity Count 3-DEHYDRONOBILIN 1 3-DESMETHYLCOLCHICINE 1 3-EPIBERCILLOGENIN 1 3-HYDROXY-FLAVONE 4 3-HYDROXYDAMSIN 1 3-INDOLEMETHANOL 1 3-METHYL-ETHER-6,8-DI-C-METHYLKAEMPFEROL 1 3-METHYL-ETHER-6,8-DI-C-METHYLQUERCETIN 1 3-METHYL-ETHER-6-C-METHYLQUERCETIN 1 3-METHYLQUERCETIN 1 3-N-BUTYL-PHTHALIDE 5 3-O-ACETYLOLEANOLIC-ACID 1 3-O-BENZOYL-URSOLIC-ACID 1 3-O-CAFFEOYLQUINIC-ACID 1 3-O-CINNAMOYL-URSOLIC-ACID 1 3-O-CROTONYL-URSOLIC-ACID 1 3-O-PALMITOYL-URSOLIC-ACID 1 3-O-PROPIONYL-URSOLIC-ACID 1 3-OXO-11-ALPHA-HYDROXYOLEAN-12-ENE-30-OIC-ACID 1 3-OXO-11-ALPHA-METHOXYOLEAN-12-ENE-30-OIC-ACID 1 3-OXO-OLEAN-9(11),12-DIENE-30-OIC-ACID 1 4',5,6,7,8-PENTAMETHOXY-FLAVONE 1 4'-DEMETHYLDEOXYPODOPHYLLUM 1 4'-DEMETHYLPODOPHYLLUM 1 4,15-DIHYDROVERNODALIN 1 4,5-DI-O-CAFFEOYLQUINIC-ACID 1 4,5-DIHYDROVERNODALIN 1 6 Chemical Activity Count 4,8'-BISCATECHIN 1 4,8-HYDROXYWITHANOLINE-E 1 4-(3,4-DIHYDROXY-BENZOYL-OXY-METHYL)-PHENYL-BETA-D-GLUCOPYRANOSIDE 1 4-ACETYLARABINOSYL-ELLAGIC-ACID 1 4-ACETYLXYLOSYL-ELLAGIC-ACID 1 4-ALLYL-PYROCATECHOL 1 4-AMINO-1,2-NAPTHOQUINONE 2 4-AMINO-4-CARBOXYCHROMAN-2-ONE 1 4-ARABINOSYL-ELLAGIC-ACID 1 4-HYDROXY-TRITRIACONTANE-16,18-DIONE 1 4-HYDROXYBENZALDEHYDE 1 4-HYDROXYCINNAMIC-ACID 1 4-HYDROXYCOUMARIN 1 4-KETOPINORESINOL 1 4-METHYLTHIOCANTHIN-6-ONE 1 4-O-CAFFEOYLQUINIC-ACID 1 4-O-METHYL-GLUCURONOXYLAN 1 4-PENTENYL-ISOTHIOCYANATE 1 4-TERPINEOL 1 4-VINYL-GUAIACOL 4 5'-DEMETHOXYDEOXYPODOPHYLLUM 1 5'-DESMETHOXY-BETA-PELTATIN-METHYL-ETHER 1 5,7-DIHYDROXY-8-METHOXY-2-METHYLCROMONE 1 5,7-DIHYDROXYCOUMARIN-7-METHYL-ETHER 1 5,7-DIMETHOXYFLAVONE 1 5,8-DIHYDROXYBENZOPYRANONE 1 5-DEOXYINGENOL-ESTER 1 7 Chemical Activity Count 5-HYDROXY-3',4,6',7,8-PENTAMETHOXYFLAVONE 1 5-HYDROXY-8-O-BETA-D-GLUCOPYRANOSYL-BENZOPYRANONE 1 5-HYDROXYTRYPTAMINE 1 5-METHOXY-PSORALEN 3 5-METHOXYCANTHIN-6-ONE 1 5-O-BETA-D-GLUCOPYRANOSYL-3-1-(4-PHENYL)-DECANE 1 5-O-CAFFEOYLQUINIC-ACID 1 6'-O-ACETYL-DAIDZIN 1 6'-O-ACETYL-GENISTIN 1 6,7,4'-TRIHYDROXYISOFLAVAN 1 6,7,4'-TRIHYDROXYISOFLAVANONE 1 6,7,4'-TRIHYDROXYISOFLAVONE 1 6,7-DI-4'-METHOXYISOFLAVAN 1 6,7-DI-4'-METHOXYISOFLAVANONE 1 6,7-DI-4'-METHOXYISOFLAVONE 1 6,7-DIHYDROXY-4'-METHOXYISOFLAVAN 1 6,7-DIHYDROXY-4'-METHOXYISOFLAVANONE 1 6,7-DIHYDROXY-4'-METHOXYISOFLAVONE 1 6,7-DIHYDROXYCOUMARIN 1 6,7-DIMETHYLAESCULETIN 1 6,7-DIMETHYLESCULETIN 1 6-(3-CARBOXY-BUT-2-ENYL)-7-HYDROXYCOUMARIN 1 6-ALPHA-SENECIOLOXYCHAPARRINONE 1 6-DEHYDROGINGERDIONE 2 6-DEOXYJACAREUBIN 1 6-ETHOXYCHELERYTHRINE 1 6-GINGERDIOL 1 8 Chemical Activity Count 6-GINGERDIONE 2 6-GINGEROL 4 6-METHYL-SULFINYL-HEXYL-ISOTHIOCYANATE 2 6-O-(2''-ACETYL-3'',4''-O-DI-P-METHOXYCINNAMOYL-ALPHA-L-RHAMNOPYRANOSYL)-CATALPOL 1 6-O-(4''-ACETYL-2'',3''-O-DI-P-METHOXYCINNAMOYL-ALPHA-L-RHAMNOPYRANOSYL)-CATALPOL 1 6-SHOGAOL 3 7,8-DIHYDROXYFLAVONE 2 7-(4'-HYDROXY-3'-METHOXYPHENYL)-1,4-PHENYL-3,5-HEPTADIONE 1 7-HYDROXY-6-HYDROMELODIENOL 1 7-HYDROXY-FLAVONE 1 7-METHOXYCOUMARIN 3 7-METHYL-ERIODICTYOL-ETHER 1 7-N-BUTOXY-3,2',5'-TRIHYDROXYFLAVONE 1 7-[3-(3,4-DIHYDROXY-4-HYDROXYMETHYL-TETRAHYDRO-FURAN-2-YLOXY)-4,5-DIHYDROXY-6- 2 HYDROXYMETHYL-TETRAHYDRO-PYRAN-2-YLOXY]...
Load more

Recommended publications
  • Integrating Complementary Medicine Into Cardiovascular Medicine
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Journal of the American College of Cardiology Vol. 46, No. 1, 2005 © 2005 by the American College of Cardiology Foundation ISSN 0735-1097/05/$30.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2005.05.031 ACCF COMPLEMENTARY MEDICINE EXPERT CONSENSUS DOCUMENT Integrating Complementary Medicine Into Cardiovascular Medicine A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents (Writing Committee to Develop an Expert Consensus Document on Complementary and Integrative Medicine) WRITING COMMITTEE MEMBERS JOHN H. K. VOGEL, MD, MACC, Chair STEVEN F. BOLLING, MD, FACC BRIAN OLSHANSKY, MD, FACC REBECCA B. COSTELLO, PHD KENNETH R. PELLETIER, MD(HC), PHD ERMINIA M. GUARNERI, MD, FACC CYNTHIA M. TRACY, MD, FACC MITCHELL W. KRUCOFF, MD, FACC, FCCP ROBERT A. VOGEL, MD, FACC JOHN C. LONGHURST, MD, PHD, FACC TASK FORCE MEMBERS ROBERT A. VOGEL, MD, FACC, Chair JONATHAN ABRAMS, MD, FACC SANJIV KAUL, MBBS, FACC JEFFREY L. ANDERSON, MD, FACC ROBERT C. LICHTENBERG, MD, FACC ERIC R. BATES, MD, FACC JONATHAN R. LINDNER, MD, FACC BRUCE R. BRODIE, MD, FACC* ROBERT A. O’ROURKE, MD, FACC† CINDY L. GRINES, MD, FACC GERALD M. POHOST, MD, FACC PETER G. DANIAS, MD, PHD, FACC* RICHARD S. SCHOFIELD, MD, FACC GABRIEL GREGORATOS, MD, FACC* SAMUEL J. SHUBROOKS, MD, FACC MARK A. HLATKY, MD, FACC CYNTHIA M. TRACY, MD, FACC* JUDITH S. HOCHMAN, MD, FACC* WILLIAM L. WINTERS, JR, MD, MACC* *Former members of Task Force; †Former chair of Task Force The recommendations set forth in this report are those of the Writing Committee and do not necessarily reflect the official position of the American College of Cardiology Foundation.
    [Show full text]
  • Candidate Gene Identification from the Wheat QTL-2DL for Resistance Against Fusarium Head Blight Based on Metabolo-Genomics Approach
    Candidate gene identification from the wheat QTL-2DL for resistance against Fusarium head blight based on metabolo-genomics approach Udaykumar Kage Department of Plant Science McGill University, Montreal, Canada August 2016 A thesis submitted to the McGill University in partial fulfillment of the requirements of the degree of Doctor of Philosophy ©Udaykumar Kage (2016) i Dedicated to my beloved parents ii TABLE OF CONTENTS TABLE OF CONTENTS………………………………………………………………………...iii LIST OF TABLES……………………………………………………………………………...viii LIST OF FIGURES………………………………………………………………………………ix LIST OF APPENDICES…………………………………………………………………………xv LIST OF ABBREVIATIONS…………………………………………………………………...xvi ABSTRACT…………………………………………………………………………………...xviii ACKNOWLEDGEMENT……………………………………………………………………...xxi PREFACE AND CONTRIBUTION OF THE AUTHORS……………………………………..01 PREFACE……………………………………………………………………………………......01 CONTRIBUTION OF THE AUTHORS………………………………………………………...02 CHAPTER I: GENERAL INTRODUCTION…………………………………………………...03 GENERAL HYPOTHESIS……………………………………………………………………...07 GENERAL OBJECTIVES……………………………………………………………………....07 CHAPTER II: REVIEW OF THE LITERATURE……………………………………………...08 2.1 Fusarium head blight of wheat at a glance…………………………………………………...08 2.1.1 Fusarium head blight epidemiology and impact on wheat production…………………08 2.1.2 FHB management practices ……………………………………………………….……10 2.1.3 FHB management through breeding for disease resistance…………………………….11 2.1.3.1 Types of Fusarium head blight resistance………………………………………….12 2.1.3.2 Molecular markers and QTL for FHB resistance……………………………….…13
    [Show full text]
  • Assessment Report on Tanacetum Parthenium (L.) Schultz Bip., Herba. Draft
    25 September 2019 EMA/HMPC/48716/2019 Committee on Herbal Medicinal Products (HMPC) Assessment report on Tanacetum parthenium (L.) Schultz Bip., herba Draft – Revision 1 Based on Article 16d(1), Article 16f and Article 16h of Directive 2001/83/EC (traditional use) Herbal substance(s) (binomial scientific name of the plant, including plant part) Tanacetum parthenium (L.) Schultz Bip., herba Herbal preparation Powdered herbal substance Pharmaceutical form(s) Herbal preparation in solid dosage forms for oral use First assessment Rapporteur G Calapai Peer-reviewer B Kroes Revision Rapporteur A Assisi Peer-reviewer B Kroes Note: This draft assessment report is published to support the public consultation of the draft European Union herbal monograph on Tanacetum parthenium (L.) Schultz Bip., herba. It is a working document, not yet edited, and shall be further developed after the release for consultation of the monograph. Interested parties are welcome to submit comments to the HMPC secretariat, which will be taken into consideration but no ‘overview of comments received during the public consultation’ will be prepared on comments that will be received on this assessment report. The publication of this draft assessment report has been agreed to facilitate the understanding by Interested Parties of the assessment that has been carried out so far and led to the preparation of the draft monograph. Official address Domenico Scarlattilaan 6 ● 1083 HS Amsterdam ● The Netherlands Address for visits and deliveries Refer to www.ema.europa.eu/how-to-find-us Send us a question Go to www.ema.europa.eu/contact Telephone +31 (0)88 781 6000 An agency of the European Union © European Medicines Agency, 2019.
    [Show full text]
  • (12) Patent Application Publication (10) Pub. N0.: US 2014/0221426 A1 Gerk Et Al
    US 20140221426A1 (19) United States (12) Patent Application Publication (10) Pub. N0.: US 2014/0221426 A1 Gerk et al. (43) Pub. Date: Aug. 7, 2014 (54) SELECTIVE METABOLIC APPROACH TO A61K 31/216 (2006.01) INCREASING ORAL BIOAVAILABILITY OF A61K 31/09 (2006.01) PHENYLEPHRINE AND OTHER PHENOLIC A61K 31/05 (2006.01) BIOACTIVITIES A61K 31/353 (2006.01) A61K 31/4525 (2006.01) (71) Applicant: VIRGINIA COMMONWEALTH A61 K 31/3 75 (2006.01) UNIVERSITY, Richmond, VA (US) A61K 31/121 (2006.01) _ _ _ (52) US. Cl. (72) Inventorsl Ph_lll_lP M- Gerk’ Rthmond, VA (Us); CPC ........... .. A61K 31/137 (2013.01); A61K 31/3 75 Wllllam H- Fa", R10hm°nda VA (Us); (2013.01); A61K 31/235 (2013.01); A61K J"sellh K- thter’ Rlchmond, VA (Us) 31/11 (2013.01); A61K 31/085 (2013.01); _ A61K 31/121 (2013.01); A61K 31/09 (21) APP1~ NO" 14/345,689 (2013.01); A61K31/05 (2013.01); A61K . _ 31/353 (2013.01);A61K31/4525 (2013.01); (22) PCT Filed. Sep. 27, 2012 A61K31/216 (201301) USPC ......... .. 514/321' 514/653' 514/474' 514/544' ( 86 ) PCT N 0 .: PCT/U52012/057588 ’ ’ 514/456;’ 514/532’ § 371 (0X1), Related US“ Application Data Presystemic metabolism in intestine of bioactives such as (60) Provisional application No. 61/539,530, ?led on Sep. phenylephrine 1? avoided by administering a Sllbject (human 27, 2011, provisional application No. 61/544,396, 0r 21111111211) the bloactlve(e-g-,Pheny1ephr1ne)1n comblnatlon ?led on Oct 7, 201 1_ With one or more inhibitors of sulfation (e.g., sulfotransferase enzymes aka SULTs).
    [Show full text]
  • A Combined Experimental and Computational Study of Chrysanthemin As a Pigment for Dye-Sensitized Solar Cells
    molecules Article A Combined Experimental and Computational Study of Chrysanthemin as a Pigment for Dye-Sensitized Solar Cells Atoumane Ndiaye 1,2 , Alle Dioum 1, Corneliu I. Oprea 2 , Anca Dumbrava 3,* , Jeanina Lungu 2, Adrian Georgescu 2, Florin Moscalu 2, Mihai A. Gîr¸tu 2,* , Aboubaker Chedikh Beye 1 and Issakha Youm 1,* 1 Department of Physics, Cheikh Anta Diop University of Dakar, 5005 Dakar-Fann, Senegal; [email protected] (A.N.); [email protected] (A.D.); [email protected] (A.C.B.) 2 Department of Physics, Ovidius University of Constanta, 900527 Constanta, Romania; [email protected] (C.I.O.); [email protected] (J.L.); [email protected] (A.G.); fl[email protected] (F.M.) 3 Department of Chemistry and Chemical Engineering, Ovidius University of Constanta, 900527 Constanta, Romania * Correspondence: [email protected] (A.D.); [email protected] (M.A.G.); [email protected] (I.Y.) Abstract: The theoretical study of chrysanthemin (cyanidin 3-glucoside) as a pigment for TiO2-based dye-sensitized solar cells (DSSCs) was performed with the GAUSSSIAN 09 simulation. The electronic spectra of neutral and anionic chrysanthemin molecules were calculated by density functional theory with B3LYP functional and DGDZVP basis set. A better energy level alignment was found for partially deprotonated molecules of chrysanthemin, with the excited photoelectron having enough energy in order to be transferred to the conduction band of TiO2 semiconductor in DSSCs. In addition, we used the raw aqueous extracts of roselle (Hibiscus sabdariffa) calyces as the source of chrysanthemin Citation: Ndiaye, A.; Dioum, A.; and the extracts with various pH values were tested in DSSCs.
    [Show full text]
  • NINDS Custom Collection II
    ACACETIN ACEBUTOLOL HYDROCHLORIDE ACECLIDINE HYDROCHLORIDE ACEMETACIN ACETAMINOPHEN ACETAMINOSALOL ACETANILIDE ACETARSOL ACETAZOLAMIDE ACETOHYDROXAMIC ACID ACETRIAZOIC ACID ACETYL TYROSINE ETHYL ESTER ACETYLCARNITINE ACETYLCHOLINE ACETYLCYSTEINE ACETYLGLUCOSAMINE ACETYLGLUTAMIC ACID ACETYL-L-LEUCINE ACETYLPHENYLALANINE ACETYLSEROTONIN ACETYLTRYPTOPHAN ACEXAMIC ACID ACIVICIN ACLACINOMYCIN A1 ACONITINE ACRIFLAVINIUM HYDROCHLORIDE ACRISORCIN ACTINONIN ACYCLOVIR ADENOSINE PHOSPHATE ADENOSINE ADRENALINE BITARTRATE AESCULIN AJMALINE AKLAVINE HYDROCHLORIDE ALANYL-dl-LEUCINE ALANYL-dl-PHENYLALANINE ALAPROCLATE ALBENDAZOLE ALBUTEROL ALEXIDINE HYDROCHLORIDE ALLANTOIN ALLOPURINOL ALMOTRIPTAN ALOIN ALPRENOLOL ALTRETAMINE ALVERINE CITRATE AMANTADINE HYDROCHLORIDE AMBROXOL HYDROCHLORIDE AMCINONIDE AMIKACIN SULFATE AMILORIDE HYDROCHLORIDE 3-AMINOBENZAMIDE gamma-AMINOBUTYRIC ACID AMINOCAPROIC ACID N- (2-AMINOETHYL)-4-CHLOROBENZAMIDE (RO-16-6491) AMINOGLUTETHIMIDE AMINOHIPPURIC ACID AMINOHYDROXYBUTYRIC ACID AMINOLEVULINIC ACID HYDROCHLORIDE AMINOPHENAZONE 3-AMINOPROPANESULPHONIC ACID AMINOPYRIDINE 9-AMINO-1,2,3,4-TETRAHYDROACRIDINE HYDROCHLORIDE AMINOTHIAZOLE AMIODARONE HYDROCHLORIDE AMIPRILOSE AMITRIPTYLINE HYDROCHLORIDE AMLODIPINE BESYLATE AMODIAQUINE DIHYDROCHLORIDE AMOXEPINE AMOXICILLIN AMPICILLIN SODIUM AMPROLIUM AMRINONE AMYGDALIN ANABASAMINE HYDROCHLORIDE ANABASINE HYDROCHLORIDE ANCITABINE HYDROCHLORIDE ANDROSTERONE SODIUM SULFATE ANIRACETAM ANISINDIONE ANISODAMINE ANISOMYCIN ANTAZOLINE PHOSPHATE ANTHRALIN ANTIMYCIN A (A1 shown) ANTIPYRINE APHYLLIC
    [Show full text]
  • Pharmacy and Poisons (Third and Fourth Schedule Amendment) Order 2017
    Q UO N T FA R U T A F E BERMUDA PHARMACY AND POISONS (THIRD AND FOURTH SCHEDULE AMENDMENT) ORDER 2017 BR 111 / 2017 The Minister responsible for health, in exercise of the power conferred by section 48A(1) of the Pharmacy and Poisons Act 1979, makes the following Order: Citation 1 This Order may be cited as the Pharmacy and Poisons (Third and Fourth Schedule Amendment) Order 2017. Repeals and replaces the Third and Fourth Schedule of the Pharmacy and Poisons Act 1979 2 The Third and Fourth Schedules to the Pharmacy and Poisons Act 1979 are repealed and replaced with— “THIRD SCHEDULE (Sections 25(6); 27(1))) DRUGS OBTAINABLE ONLY ON PRESCRIPTION EXCEPT WHERE SPECIFIED IN THE FOURTH SCHEDULE (PART I AND PART II) Note: The following annotations used in this Schedule have the following meanings: md (maximum dose) i.e. the maximum quantity of the substance contained in the amount of a medicinal product which is recommended to be taken or administered at any one time. 1 PHARMACY AND POISONS (THIRD AND FOURTH SCHEDULE AMENDMENT) ORDER 2017 mdd (maximum daily dose) i.e. the maximum quantity of the substance that is contained in the amount of a medicinal product which is recommended to be taken or administered in any period of 24 hours. mg milligram ms (maximum strength) i.e. either or, if so specified, both of the following: (a) the maximum quantity of the substance by weight or volume that is contained in the dosage unit of a medicinal product; or (b) the maximum percentage of the substance contained in a medicinal product calculated in terms of w/w, w/v, v/w, or v/v, as appropriate.
    [Show full text]
  • The Phytochemistry of Cherokee Aromatic Medicinal Plants
    medicines Review The Phytochemistry of Cherokee Aromatic Medicinal Plants William N. Setzer 1,2 1 Department of Chemistry, University of Alabama in Huntsville, Huntsville, AL 35899, USA; [email protected]; Tel.: +1-256-824-6519 2 Aromatic Plant Research Center, 230 N 1200 E, Suite 102, Lehi, UT 84043, USA Received: 25 October 2018; Accepted: 8 November 2018; Published: 12 November 2018 Abstract: Background: Native Americans have had a rich ethnobotanical heritage for treating diseases, ailments, and injuries. Cherokee traditional medicine has provided numerous aromatic and medicinal plants that not only were used by the Cherokee people, but were also adopted for use by European settlers in North America. Methods: The aim of this review was to examine the Cherokee ethnobotanical literature and the published phytochemical investigations on Cherokee medicinal plants and to correlate phytochemical constituents with traditional uses and biological activities. Results: Several Cherokee medicinal plants are still in use today as herbal medicines, including, for example, yarrow (Achillea millefolium), black cohosh (Cimicifuga racemosa), American ginseng (Panax quinquefolius), and blue skullcap (Scutellaria lateriflora). This review presents a summary of the traditional uses, phytochemical constituents, and biological activities of Cherokee aromatic and medicinal plants. Conclusions: The list is not complete, however, as there is still much work needed in phytochemical investigation and pharmacological evaluation of many traditional herbal medicines. Keywords: Cherokee; Native American; traditional herbal medicine; chemical constituents; pharmacology 1. Introduction Natural products have been an important source of medicinal agents throughout history and modern medicine continues to rely on traditional knowledge for treatment of human maladies [1]. Traditional medicines such as Traditional Chinese Medicine [2], Ayurvedic [3], and medicinal plants from Latin America [4] have proven to be rich resources of biologically active compounds and potential new drugs.
    [Show full text]
  • Shilin Yang Doctor of Philosophy
    PHYTOCHEMICAL STUDIES OF ARTEMISIA ANNUA L. THESIS Presented by SHILIN YANG For the Degree of DOCTOR OF PHILOSOPHY of the UNIVERSITY OF LONDON DEPARTMENT OF PHARMACOGNOSY THE SCHOOL OF PHARMACY THE UNIVERSITY OF LONDON BRUNSWICK SQUARE, LONDON WC1N 1AX ProQuest Number: U063742 All rights reserved INFORMATION TO ALL USERS The quality of this reproduction is dependent upon the quality of the copy submitted. In the unlikely event that the author did not send a com plete manuscript and there are missing pages, these will be noted. Also, if material had to be removed, a note will indicate the deletion. uest ProQuest U063742 Published by ProQuest LLC(2017). Copyright of the Dissertation is held by the Author. All rights reserved. This work is protected against unauthorized copying under Title 17, United States C ode Microform Edition © ProQuest LLC. ProQuest LLC. 789 East Eisenhower Parkway P.O. Box 1346 Ann Arbor, Ml 48106- 1346 ACKNOWLEDGEMENT I wish to express my sincere gratitude to Professor J.D. Phillipson and Dr. M.J.O’Neill for their supervision throughout the course of studies. I would especially like to thank Dr. M.F.Roberts for her great help. I like to thank Dr. K.C.S.C.Liu and B.C.Homeyer for their great help. My sincere thanks to Mrs.J.B.Hallsworth for her help. I am very grateful to the staff of the MS Spectroscopy Unit and NMR Unit of the School of Pharmacy, and the staff of the NMR Unit, King’s College, University of London, for running the MS and NMR spectra.
    [Show full text]
  • IN SILICO ANALYSIS of FUNCTIONAL Snps of ALOX12 GENE and IDENTIFICATION of PHARMACOLOGICALLY SIGNIFICANT FLAVONOIDS AS
    Tulasidharan Suja Saranya et al. Int. Res. J. Pharm. 2014, 5 (6) INTERNATIONAL RESEARCH JOURNAL OF PHARMACY www.irjponline.com ISSN 2230 – 8407 Research Article IN SILICO ANALYSIS OF FUNCTIONAL SNPs OF ALOX12 GENE AND IDENTIFICATION OF PHARMACOLOGICALLY SIGNIFICANT FLAVONOIDS AS LIPOXYGENASE INHIBITORS Tulasidharan Suja Saranya, K.S. Silvipriya, Manakadan Asha Asokan* Department of Pharmaceutical Chemistry, Amrita School of Pharmacy, Amrita Viswa Vidyapeetham University, AIMS Health Sciences Campus, Kochi, Kerala, India *Corresponding Author Email: [email protected] Article Received on: 20/04/14 Revised on: 08/05/14 Approved for publication: 22/06/14 DOI: 10.7897/2230-8407.0506103 ABSTRACT Cancer is a disease affecting any part of the body and in comparison with normal cells there is an elevated level of lipoxygenase enzyme in different cancer cells. Thus generation of lipoxygenase enzyme inhibitors have suggested being valuable. Individual variation was identified by the functional effects of Single Nucleotide Polymorphisms (SNPs). 696 SNPs were identified from the ALOX12 gene, out of which 73 were in the coding non-synonymous region, from which 8 were found to be damaging. In silico analysis was performed to determine naturally occurring flavonoids such as isoflavones having the basic 3- phenylchromen-4-one skeleton for the pharmacological activity, like Genistein, Diadzein, Irilone, Orobol and Pseudobaptigenin. O-methylated isoflavones such as Biochanin, Calycosin, Formononetin, Glycitein, Irigenin, 5-O-Methylgenistein, Pratensein, Prunetin, ψ-Tectorigenin, Retusin and Tectorigenine were also used for the study. Other natural products like Aesculetin, a coumarin derivative; flavones such as ajoene and baicalein were also used for the comparative study of these natural compounds along with acteoside and nordihydroguaiaretic acid (antioxidants) and active inhibitors like Diethylcarbamazine, Zileuton and Azelastine as standard for the computational analysis.
    [Show full text]
  • Phytochem Referenzsubstanzen
    High pure reference substances Phytochem Hochreine Standardsubstanzen for research and quality für Forschung und management Referenzsubstanzen Qualitätssicherung Nummer Name Synonym CAS FW Formel Literatur 01.286. ABIETIC ACID Sylvic acid [514-10-3] 302.46 C20H30O2 01.030. L-ABRINE N-a-Methyl-L-tryptophan [526-31-8] 218.26 C12H14N2O2 Merck Index 11,5 01.031. (+)-ABSCISIC ACID [21293-29-8] 264.33 C15H20O4 Merck Index 11,6 01.032. (+/-)-ABSCISIC ACID ABA; Dormin [14375-45-2] 264.33 C15H20O4 Merck Index 11,6 01.002. ABSINTHIN Absinthiin, Absynthin [1362-42-1] 496,64 C30H40O6 Merck Index 12,8 01.033. ACACETIN 5,7-Dihydroxy-4'-methoxyflavone; Linarigenin [480-44-4] 284.28 C16H12O5 Merck Index 11,9 01.287. ACACETIN Apigenin-4´methylester [480-44-4] 284.28 C16H12O5 01.034. ACACETIN-7-NEOHESPERIDOSIDE Fortunellin [20633-93-6] 610.60 C28H32O14 01.035. ACACETIN-7-RUTINOSIDE Linarin [480-36-4] 592.57 C28H32O14 Merck Index 11,5376 01.036. 2-ACETAMIDO-2-DEOXY-1,3,4,6-TETRA-O- a-D-Glucosamine pentaacetate 389.37 C16H23NO10 ACETYL-a-D-GLUCOPYRANOSE 01.037. 2-ACETAMIDO-2-DEOXY-1,3,4,6-TETRA-O- b-D-Glucosamine pentaacetate [7772-79-4] 389.37 C16H23NO10 ACETYL-b-D-GLUCOPYRANOSE> 01.038. 2-ACETAMIDO-2-DEOXY-3,4,6-TRI-O-ACETYL- Acetochloro-a-D-glucosamine [3068-34-6] 365.77 C14H20ClNO8 a-D-GLUCOPYRANOSYLCHLORIDE - 1 - High pure reference substances Phytochem Hochreine Standardsubstanzen for research and quality für Forschung und management Referenzsubstanzen Qualitätssicherung Nummer Name Synonym CAS FW Formel Literatur 01.039.
    [Show full text]
  • A Case Report of Accidental Intoxication Following Ingestion of Foxglove Confused with Borage: High Digoxinemia Without Major Complications
    Hindawi Case Reports in Cardiology Volume 2019, Article ID 9707428, 6 pages https://doi.org/10.1155/2019/9707428 Case Report A Case Report of Accidental Intoxication following Ingestion of Foxglove Confused with Borage: High Digoxinemia without Major Complications Maria Silvia Negroni,1 Arianna Marengo,2 Donatella Caruso,3 Alessandro Tayar,1 Patrizia Rubiolo,2 Flavio Giavarini,3 Simone Persampieri,1 Enrico Sangiovanni,3 Franca Davanzo,4 Stefano Carugo,1 Maria Laura Colombo,2 and Mario Dell’Agli 3 1Division of Cardiology, San Paolo Hospital, Department of Health Sciences, University of Milan, Via A. Di Rudini 8, Milan, Italy 2Department of Drug Science and Technology, Università degli Studi di Torino, Via Pietro Giuria 9, Turin, Italy 3Department of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano, Via Balzaretti 9, Milan, Italy 4Poison Control Centre of Milan, Niguarda Ca’ Granda Hospital, Milan, Italy Correspondence should be addressed to Mario Dell’Agli; [email protected] Received 12 June 2019; Accepted 13 November 2019; Published 29 November 2019 Academic Editor: Kuan-Rau Chiou Copyright © 2019 Maria Silvia Negroni et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Foxglove (Digitalis purpurea L.) leaves are frequently confused with borage (Borago officinalis L.), which is traditionally used as a food ingredient. Due to the presence of the cardiac glycosides, mostly digitoxin, foxglove leaves are poisonous to human and may be fatal if ingested. A 55-year-old Caucasian woman complaining weakness, fatigue, nausea, and vomiting was admitted to the Emergency Department.
    [Show full text]